STEPHANIE BRUTON: Open Payments
NPI 1932692993 · STAUNTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,781 in 261 payments from 16 companies in 2025. Trend: 2023 $2,843 · 2024 $3,614 · 2025 $3,781
Food & beverage: $3,781
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 79 | $673 |
| ABBVIE INC. | 34 | $650 |
| E.R. Squibb & Sons, L.L.C. | 16 | $417 |
| Alkermes, Inc. | 26 | $391 |
| Otsuka America Pharmaceutical, Inc. | 30 | $349 |
| Neurocrine BioSciences, Inc. | 19 | $333 |
| Vanda Pharmaceuticals Inc. | 12 | $298 |
| Lundbeck LLC | 19 | $234 |
| Teva Pharmaceuticals USA, Inc. | 13 | $169 |
| Janssen Pharmaceuticals, Inc | 2 | $63 |
Products named: CAPLYTA, VRAYLAR, REXULTI, COBENFY, INGREZZA, ARISTADA, FANAPT, AUSTEDO XR.
Industry payments across VA — which companies pay providers there.
